PIC
Portland Investment Counsel Portfolio holdings
AUM $340M
1-Year Return
50.8%
This Quarter Return
+3.3%
1 Year Return
+50.8%
3 Year Return
+61.43%
5 Year Return
+85.27%
10 Year Return
–
AUM
$329M
AUM Growth
-$60.6M
(-16%)
Cap. Flow
-$68.1M
Cap. Flow
% of AUM
-20.7%
Top 10 Holdings %
Top 10 Hldgs %
82.69%
Holding
57
New
5
Increased
16
Reduced
2
Closed
8
Top Buys
| 1 |
Cenovus Energy
CVE
|
+$19.9M |
| 2 |
Magna International
MGA
|
+$5.97M |
| 3 |
Ares Management
ARES
|
+$1.13M |
| 4 |
Toronto Dominion Bank
TD
|
+$629K |
| 5 |
Carnival Corp
CCL
|
+$391K |
Top Sells
| 1 |
Kraft Heinz
KHC
|
+$23.8M |
| 2 |
Verizon
VZ
|
+$22.2M |
| 3 |
Nutrien
NTR
|
+$18.1M |
| 4 |
AT&T
T
|
+$12M |
| 5 |
Citigroup
C
|
+$11.3M |
Sector Composition
| 1 | Financials | 43.64% |
| 2 | Healthcare | 23.26% |
| 3 | Energy | 15.65% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Utilities | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Microsoft
MSFT
$3.82T
| $802K | 0.24% |
2,137
| – | – |
|
27
NVIDIA
NVDA
$4.27T
| $753K | 0.23% |
6,948
+1,877
| +37% | +$203K |
|
28
Mastercard
MA
$528B
| $747K | 0.23% |
1,363
| – | – |
|
29
Liberty Latin America Class C
LILAK
$1.54B
| $728K | 0.22% |
115,803
| – | – |
|
30
Eli Lilly
LLY
$689B
| $714K | 0.22% |
865
| – | – |
|
31
TransDigm Group
TDG
$72.6B
| $686K | 0.21% |
496
| – | – |
|
|
VRN
32
DELISTED
Veren
VRN
| $670K | 0.2% |
101,200
| – | – |
|
33
BWX Technologies
BWXT
$16B
| $641K | 0.19% |
6,500
+2,500
| +63% | +$247K |
|
34
Baytex Energy
BTE
$1.98B
| $622K | 0.19% |
280,300
| – | – |
|
35
HEICO
HEI
$45.4B
| $600K | 0.18% |
2,244
| – | – |
|
36
NuScale Power
SMR
$4.95B
| $566K | 0.17% |
40,000
| – | – |
|
37
Constellation Energy
CEG
$102B
| $524K | 0.16% |
2,600
+800
| +44% | +$161K |
|
38
Centrus Energy
LEU
$4.27B
| $497K | 0.15% |
10,000
+2,000
| +25% | +$99.4K |
|
39
Perspective Therapeutics
CATX
$251M
| $405K | 0.12% |
190,000
+40,000
| +27% | +$85.2K |
|
40
Icon
ICLR
$13.5B
| $350K | 0.11% |
2,000
| – | – |
|
41
Iovance Biotherapeutics
IOVA
$850M
| $333K | 0.1% |
100,000
+45,000
| +82% | +$150K |
|
42
Bloom Energy
BE
$16.8B
| $295K | 0.09% |
+15,000
| New | +$295K |
|
43
Okta
OKTA
$15.8B
| $258K | 0.08% |
+2,450
| New | +$258K |
|
44
Olema Pharmaceuticals
OLMA
$553M
| $188K | 0.06% |
50,000
+25,000
| +100% | +$94K |
|
|
BCYC
45
Bicycle Therapeutics
BCYC
$496M
| $127K | 0.04% |
+15,000
| New | +$127K |
|
46
Arvinas
ARVN
$557M
| $98.3K | 0.03% |
+14,000
| New | +$98.3K |
|
47
Plug Power
PLUG
$1.88B
| $67.5K | 0.02% |
50,000
| – | – |
|
48
Relay Therapeutics
RLAY
$731M
| $26.2K | 0.01% |
10,000
| – | – |
|
|
49
Citigroup
C
$184B
| – | – |
-160,500
| Closed | -$11.3M |
|
50
CrowdStrike
CRWD
$112B
| – | – |
-843
| Closed | -$288K |
|